EN
TR
Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü
Abstract
INTRODUCTION: In terms of quality of life, it was aimed to reveal the relationship between obesity and the presence of metabolic syndrome in prediabetic or normoglycemic people.
METHODS: A total of 159 patients, 18-65 years of age, were included in the study. Body mass index (BMI) values of 30 kg/m² and above were accepted as obesity. Quality of life was evaluated with short form-36 (SF-36).
RESULTS: According to the SF-36 quality of life assessment of all patients; the median values of physical component, mental component and total score were found to be significantly lower in patients with obesity than those without obesity (p=0.006, p=0.040, p=0.009, respectively). In the subgroup analysis of individuals without metabolic syndrome, according to the SF-36 quality of life assessment; the median values of physical component, mental component and total score were similar in patients with obesity compared to those without obesity (p=0.379, p=0.574, p=0.525, respectively).
Similarly, according to the SF-36 quality of life assessment of all patients; the median values of physical component, mental component and total score were found to be significantly lower in patients with MetS than those without MetS (p<0.001, p<0.001, p<0.001, respectively). In the subgroup analysis of individuals with obesity, according to the SF-36 quality of life assessment; the median values of physical component, mental component and total score were similar in patients with MetS compared to those without MetS (p=0.001, p=0.009, p=0.003, respectively).
DISCUSSION and CONCLUSION: Through this study, it has been shown again that the quality of life is reduced in those with obesity. In addition, our findings show that the reduction in the quality of life of patients with obesity mainly points to the presence of MetS.
Keywords
Supporting Institution
yoktur
Project Number
yoktur
Thanks
yoktur
References
- Vanleerberghe P, De Witte N, Claes C, et al. The quality of life of older people aging in place: a literature review. Qual Life Res. 2017 Nov;26(11):2899-2907.
- Gouw VXH, Jiang Y, Seah B, et al. Effectiveness of internal Qigong on quality of life, depressive symptoms and self-efficacy among community-dwelling older adults with chronic disease: A systematic review and meta-analysis. Int J Nurs Stud. 2019 Nov;99:103378.
- Megari K. Quality of Life in Chronic Disease Patients. Health Psychol Res. 2013 Sep 23;1(3):e27.
- Sonmez A, Yumuk V, Haymana C, et al. TEMD Study Group. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Obes Facts. 2019;12(2):167-178.
- Masmiquel L, Leiter LA, Vidal J, et al. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol. 2016 Feb; 15(1): 29.
- Satman I, Omer B, Tutuncu Y, et al. TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013 Feb;28(2):169-80.
- Payne ME, Porter Starr KN, Orenduff M, et al. Quality of Life and Mental Health in Older Adults with Obesity and Frailty: Associations with a Weight Loss Intervention. J Nutr Health Aging. 2018;22(10):1259-1265.
- World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii, 1–253.
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Research Article
Authors
Publication Date
December 21, 2021
Submission Date
February 10, 2021
Acceptance Date
October 18, 2021
Published in Issue
Year 2021 Volume: 10 Number: 3
APA
Topaloğlu, U. S. (2021). Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Medical Journal, 10(3), 353-359. https://doi.org/10.47493/abantmedj.877925
AMA
1.Topaloğlu US. Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Med J. 2021;10(3):353-359. doi:10.47493/abantmedj.877925
Chicago
Topaloğlu, Ulaş Serkan. 2021. “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”. Abant Medical Journal 10 (3): 353-59. https://doi.org/10.47493/abantmedj.877925.
EndNote
Topaloğlu US (December 1, 2021) Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Medical Journal 10 3 353–359.
IEEE
[1]U. S. Topaloğlu, “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”, Abant Med J, vol. 10, no. 3, pp. 353–359, Dec. 2021, doi: 10.47493/abantmedj.877925.
ISNAD
Topaloğlu, Ulaş Serkan. “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”. Abant Medical Journal 10/3 (December 1, 2021): 353-359. https://doi.org/10.47493/abantmedj.877925.
JAMA
1.Topaloğlu US. Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Med J. 2021;10:353–359.
MLA
Topaloğlu, Ulaş Serkan. “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”. Abant Medical Journal, vol. 10, no. 3, Dec. 2021, pp. 353-9, doi:10.47493/abantmedj.877925.
Vancouver
1.Ulaş Serkan Topaloğlu. Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Med J. 2021 Dec. 1;10(3):353-9. doi:10.47493/abantmedj.877925